Suppr超能文献

麦角酸二乙酰胺:一种“有用”的药物?

Lysergic acid diethylamide: a drug of 'use'?

作者信息

Das Saibal, Barnwal Preeti, Ramasamy Anand, Sen Sumalya, Mondal Somnath

机构信息

Department of Pharmacology, Christian Medical College, Vellore, 632002, India.

Jamia Hamdard (Hamdard University), New Delhi, India.

出版信息

Ther Adv Psychopharmacol. 2016 Jun;6(3):214-28. doi: 10.1177/2045125316640440. Epub 2016 Mar 23.

Abstract

Lysergic acid diethylamide (LSD), described as a classical hallucinogen, began its journey from the middle of the last century following an accidental discovery. Since then, it was used as a popular and notorious substance of abuse in various parts of the world. Its beneficial role as an adjunct to psychotherapy was much unknown, until some 'benevolent' experiments were carried out over time to explore some of its potential uses. But, many of its effects were unclear and seemed to be a psychedelic enigma. In this review article, we have described the receptor pharmacology, mechanism of action, effects and adverse effects of LSD on the normal body system. We have also highlighted its addictive potentials and the chances of developing tolerance. We have assimilated some of the interesting therapeutic uses of this drug, such as an antianxiety agent, a creativity enhancer, a suggestibility enhancer, and a performance enhancer. We have also described LSD to be successfully used in drug and alcohol dependence, and as a part of psychedelic peak therapy in terminally ill patients. The relevant chronological history and literature in the light of present knowledge and scenarios have been discussed. Based on available evidence, LSD could be tried therapeutically in certain specific conditions under controlled settings. But as we mention, due to all the safety concerns, the use of this nonaddictive 'entheogen' in actual practice warrants a lot of expertise, caution, cooperation and ethical considerations.

摘要

麦角酸二乙酰胺(LSD),被描述为一种经典致幻剂,自上世纪中叶一次意外发现后开始进入人们视野。从那时起,它在世界各地成为一种广为人知且声名狼藉的滥用物质。其作为心理治疗辅助药物的有益作用在很长时间内鲜为人知,直到随着时间推移进行了一些“善意”实验来探索其一些潜在用途。但是,它的许多作用尚不清楚,似乎是一个迷幻谜团。在这篇综述文章中,我们描述了LSD对正常身体系统的受体药理学、作用机制、效应和不良反应。我们还强调了其成瘾潜力以及产生耐受性的可能性。我们总结了这种药物一些有趣的治疗用途,比如作为抗焦虑剂、创造力增强剂、暗示性增强剂和表现增强剂。我们还描述了LSD已成功用于药物和酒精依赖治疗,以及作为绝症患者迷幻巅峰疗法的一部分。根据现有知识和情况讨论了相关的编年历史和文献。基于现有证据,在特定条件下的受控环境中可以尝试对LSD进行治疗性应用。但是正如我们所提到的,由于所有这些安全问题,在实际应用中使用这种非成瘾性“致幻剂”需要大量专业知识、谨慎态度、合作以及伦理考量。

相似文献

1
Lysergic acid diethylamide: a drug of 'use'?麦角酸二乙酰胺:一种“有用”的药物?
Ther Adv Psychopharmacol. 2016 Jun;6(3):214-28. doi: 10.1177/2045125316640440. Epub 2016 Mar 23.
6
Psychedelic-Assisted Group Therapy: A Systematic Review.迷幻辅助团体治疗:系统评价。
J Psychoactive Drugs. 2019 Apr-Jun;51(2):174-188. doi: 10.1080/02791072.2019.1593559. Epub 2019 Apr 5.
7
Beyond LSD: A Broader Psychedelic Zeitgeist during the Early to Mid-20 Century.超越 LSD:20 世纪早期到中期更广泛的迷幻思潮。
J Psychoactive Drugs. 2019 Jul-Aug;51(3):210-217. doi: 10.1080/02791072.2019.1581961. Epub 2019 Mar 6.

引用本文的文献

7
Use and abuse of dissociative and psychedelic drugs in adolescence.青少年时期致幻剂和迷幻剂的使用与滥用。
Pharmacol Biochem Behav. 2021 Apr;203:173129. doi: 10.1016/j.pbb.2021.173129. Epub 2021 Jan 28.

本文引用的文献

1
Classic hallucinogens in the treatment of addictions.经典致幻剂在成瘾治疗中的应用。
Prog Neuropsychopharmacol Biol Psychiatry. 2016 Jan 4;64:250-8. doi: 10.1016/j.pnpbp.2015.03.002. Epub 2015 Mar 14.
2
Drug models of schizophrenia.精神分裂症的药物模型。
Ther Adv Psychopharmacol. 2015 Feb;5(1):43-58. doi: 10.1177/2045125314557797.
4
Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects.健康受试者中麦角酸二乙基酰胺的急性效应。
Biol Psychiatry. 2015 Oct 15;78(8):544-53. doi: 10.1016/j.biopsych.2014.11.015. Epub 2014 Nov 29.
8
LSD enhances suggestibility in healthy volunteers.麦角酸二乙酰胺(LSD)会增强健康志愿者的受暗示性。
Psychopharmacology (Berl). 2015 Feb;232(4):785-94. doi: 10.1007/s00213-014-3714-z. Epub 2014 Sep 23.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验